| Description | Lutikizumab (ABT-981) is a dual variable domain immunoglobulin targeting and inhibiting both IL-1α and IL-1β. This compound is under investigation for its potential application in osteoarthritis research [1]. |
| molecular weight | N/A |
| CAS | 1791411-57-8 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 years |